Guidance Document for Industry - Review of Drug Brand Names

Description

To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.

Resources

Name Format Description Link
Guidance Document for Industry - Review of Drug Brand Names HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/guidance-document-industry-review-drug-brand-names.html#a1
Guidance Document for Industry - Review of Drug Brand Names HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/rapports-publications/medeffet-canada/ligne-directrice-intention-industrie-examen-marques-nominatives-medicament.html#a

Tags

Topics

Categories